Use of internal-external diversion stent in open pyeloplasty in patients under one year of age

Autor: CM Gálvez Estévez, MP Valdivieso Castro, A Galbarriatu Gutiérrez, I Tuduri Limousin, TM Cardenal Alonso-Allende, L Álvarez Martínez, JL Blanco Bruned

Publikováno v: Cirugía Pediátrica. 36:28-32

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d9fb0a0d8de285b097c80243f325528
https://doi.org/10.54847/cp.2023.01.17

[GESIDA Consensus document on the use of resistance studies in clinical practice]

Autor: Jm, Gatell, Jl, Blanco, Alcamí J, Antela A, Arrizabalaga J, Jl, Casado, Clotet B, Delgado R, Erice A, Guerra L, Guerrero A, Ja, Iribarren, Leal M, Jc, López, Menéndez-Arias L, Jm, Miró, Moreno S, Jl, Pérez, Pumarola T, Rubio R, Ruiz L, Jm, Santamaría, Vicente Soriano, Telenti A, Viciana P

Publikováno v: Publons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e6a9d187dfd7ef7bb1bce8a6c09931fc
https://pubmed.ncbi.nlm.nih.gov/11428062

Direct isolation (without enrichment) of Listeria monocytogenes in milk

Autor: Dominguez L, Briones V, Blanco M, JOSE FRANCISCO FERNANDEZ-GARAYZABAL, Jl, Blanco, Ja, Vazquez, Suarez G

Publikováno v: Scopus-Elsevier
Europe PubMed Central

In the present work we have developed a direct method (without enrichment) for the isolation of listeriae in milk, using the combinated action of SDS (sodium dodecyl sulphate), centrifugation and selective media. It is possible to identify even 0.5 l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::96e49224e3823ae70cf76bbf6fd43a67
http://www.scopus.com/inward/record.url?eid=2-s2.0-0024947812&partnerID=MN8TOARS

Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain.

Autor: Izquierdo R; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Suárez-García I; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Group, Department of Internal Medicine, Infanta Sofia University Hospital, Infanta Sofia University Hospital and Henares University Hospital Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain.; European University of Madrid, Madrid, Spain., Gómez-García T; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Marco-Sánchez C; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain., Puente-Ferreiro J; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain., Moreno C; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Diaz A; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Cabello-Clotet N; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Internal Medicine Department, San Carlos Clinical Hospital, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), Madrid, Spain.; Complutense University of Madrid, Madrid, Spain., Vinuesa D; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, San Cecilio Clinical University Hospital, Granada, Spain., Blanco JL; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Clínic Barcelona hospital, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Melús E; Department of Infectious Diseases, San Pedro University Hospital, Logroño, Spain., Gómez-Ayerbe C; Infectious Diseases Unit, Virgen de la Victoria University Hospital, Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA Plataforma-BIONAND), Málaga, Spain., Olalla J; Internal Medicine Department, Costa del Sol University Hospital, Marbella, Spain., Riera M; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Internal Medicine Department, Son Espases University Hospital, Illes Balears Health Research Institute (IdISBa), Palma de Mallorca, Spain., Bernardino JI; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; HIV Unit, Internal Medicine, Department, Hospital La Paz-Carlos III, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., de López Bernaldo de Quirós JC; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Gregorio Marañón General University Hospital, Madrid, Spain., Moreno S; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, University Hospital Ramón y Cajal, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.; Department of Medicine, Alcalá University, Madrid, Spain., Jarrín I; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.

Publikováno v: HIV medicine [HIV Med] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.

Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study.

Autor: de Lazzari E; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Nomah DK; Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Dept Salut, Generalitat de Catalunya, Badalona, Spain., Blanco JL; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Rico N; Core Laboratory. Biological Diagnostic Center. Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Filella X; Core Laboratory. Biological Diagnostic Center. Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Egri N; Department of Immunology, Centre de Diagnòstic Biomèdic, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Ruiz R; Core Laboratory. Biological Diagnostic Center. Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Marcos MA; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain; Microbiology Department, Hospital Clinic of Barcelona, ISGlobal, University of Barcelona, Barcelona, Spain., Mosquera MDM; Microbiology Department, Hospital Clinic of Barcelona, ISGlobal, University of Barcelona, Barcelona, Spain., Alcamí J; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Sánchez-Palomino S; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Bruguera A; Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Dept Salut, Generalitat de Catalunya, Badalona, Spain., Hurtado C; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain., Rovira C; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain., Ambrosioni J; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Chivite I; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain., González-Cordón A; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Inciarte A; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain., Laguno M; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Martínez-Rebollar M; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain., de la Mora L; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain., Torres B; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Díaz Y; Centre Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Dept Salut, Generalitat de Catalunya, Badalona, Spain., Martínez E; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Mallolas J; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain., Miro JM; HIV Unit Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona. Barcelona, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jmmiro@ub.edu.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Oct 18; Vol. 149, pp. 107266. Date of Electronic Publication: 2024 Oct 18.